prescription drug prices

A bill expanding the powers of the Prescription Drug Affordability Board passed the Senate Wednesday.

Lawmakers want to expand the authority to negotiate drug prices with companies.

Move could help reduce drug costs for the state.

The plan allows the state to set upper payment limits on drugs.

Board approves structure to put upper payment limits on some drugs.

Maryland's Prescription Drug Affordability Board is tasked with reducing the cost of medication. The five member board has several tools at its disposal.

Some Inflation Reduction Act provisions will expire in 2025.

The next step is for the board to conduct cost reviews of the drugs.

The suit claims the companies conspired to increase the cost of insulin.

A new bill would allow the board to review drugs for the whole state.